{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CAP-IT&page=9", "query": { "intervention": "CAP-IT", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 326, "total_pages": 33, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CAP-IT&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CAP-IT&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T10:08:34.025Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02268305", "title": "The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "MSM 1000mg twice a day (6000 mgs)", "type": "DRUG" }, { "name": "Placebo capsules twice a day", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mike O'Callaghan Military Hospital", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2015-02", "completion_date": "2018-06-05", "has_results": true, "last_update_posted_date": "2024-04-05", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 1, "location_summary": "Nellis Air Force Base, Nevada", "locations": [ { "city": "Nellis Air Force Base", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT02268305" }, { "nct_id": "NCT07652346", "title": "The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vitamin C Levels", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy", "Suboptimal Vitamin C Levels", "Adequate Vitamin C Levels" ], "interventions": [ { "name": "Qualia Vitamin C+", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Qualia Life Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 152, "start_date": "2026-08-07", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 1, "location_summary": "Carlsbad, California", "locations": [ { "city": "Carlsbad", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07652346" }, { "nct_id": "NCT04855422", "title": "Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Transplant; Complication, Rejection" ], "interventions": [ { "name": "Allosure", "type": "DIAGNOSTIC_TEST" }, { "name": "AlloMap", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2021-07-14", "completion_date": "2026-06-22", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04855422" }, { "nct_id": "NCT02735707", "title": "Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Tract Diseases", "Influenza (Pandemic)", "Influenza", "Community Acquired Pneumonia", "Community Acquired Pneumonia (CAP)", "Community Acquired Pneumonia, Severe", "COVID-19", "Respiratory Tract Infection Acute", "Respiratory Tract Infections (RTI)", "SARS CoV 2 Infection" ], "interventions": [ { "name": "Ceftriaxone + Macrolide", "type": "DRUG" }, { "name": "Moxifloxacin or Levofloxacin", "type": "DRUG" }, { "name": "Piperacillin-tazobactam + Macrolide", "type": "DRUG" }, { "name": "Ceftaroline + Macrolide", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate + Macrolide", "type": "DRUG" }, { "name": "Standard course macrolide", "type": "DRUG" }, { "name": "Extended course macrolide", "type": "DRUG" }, { "name": "No systemic corticosteroid", "type": "OTHER" }, { "name": "Fixed-duration Hydrocortisone", "type": "DRUG" }, { "name": "Shock-dependent hydrocortisone", "type": "DRUG" }, { "name": "Fixed-duration higher dose Hydrocortisone", "type": "DRUG" }, { "name": "No antiviral agent for influenza", "type": "OTHER" }, { "name": "Five-days oseltamivir", "type": "DRUG" }, { "name": "Ten-days oseltamivir", "type": "DRUG" }, { "name": "No antiviral agent for COVID-19", "type": "OTHER" }, { "name": "Lopinavir / Ritonavir", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Hydroxychloroquine + lopinavir/ritonavir", "type": "DRUG" }, { "name": "Ivermectin", "type": "DRUG" }, { "name": "No immune modulation for COVID-19", "type": "OTHER" }, { "name": "Interferon beta-1a", "type": "DRUG" }, { "name": "Anakinra", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Sarilumab", "type": "DRUG" }, { "name": "Local standard venous thromboprophylaxis", "type": "DRUG" }, { "name": "Therapeutic dose anticoagulation", "type": "DRUG" }, { "name": "Conventional low dose thromboprophylaxis", "type": "DRUG" }, { "name": "Intermediate dose thromboprophylaxis", "type": "DRUG" }, { "name": "Continuation of therapeutic dose anticoagulation", "type": "DRUG" }, { "name": "No immunoglobulin", "type": "OTHER" }, { "name": "Convalescent plasma", "type": "BIOLOGICAL" }, { "name": "Delayed administration of convalescent plasma", "type": "BIOLOGICAL" }, { "name": "No vitamin C", "type": "OTHER" }, { "name": "Vitamin C", "type": "DRUG" }, { "name": "No antiplatelet", "type": "OTHER" }, { "name": "Aspirin", "type": "DRUG" }, { "name": "P2Y12 inhibitor", "type": "DRUG" }, { "name": "No simvastatin", "type": "OTHER" }, { "name": "Simvastatin", "type": "DRUG" }, { "name": "Eritoran", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" }, { "name": "Clinician-preferred mechanical ventilation strategy", "type": "PROCEDURE" }, { "name": "Protocolised mechanical ventilation strategy", "type": "PROCEDURE" }, { "name": "No renin-angiotensin system inhibitor", "type": "OTHER" }, { "name": "Angiotensin converting enzyme inhibitor", "type": "DRUG" }, { "name": "Angiotensin Receptor Blockers", "type": "DRUG" }, { "name": "ARB + DMX-200", "type": "DRUG" }, { "name": "No cysteamine", "type": "OTHER" }, { "name": "Cysteamine", "type": "DRUG" }, { "name": "Fixed-duration dexamethasone", "type": "DRUG" }, { "name": "Baloxavir Marboxil", "type": "DRUG" }, { "name": "Five-days oseltamivir + baloxavir marboxil", "type": "DRUG" }, { "name": "Ten-days oseltamivir + baloxavir marboxil", "type": "DRUG" }, { "name": "No endothelial modulator", "type": "OTHER" }, { "name": "Imatinib", "type": "DRUG" }, { "name": "No Immune Modulator for Influenza", "type": "OTHER" }, { "name": "Baricitinib", "type": "DRUG" }, { "name": "Nirmatrelvir/ritonavir", "type": "DRUG" }, { "name": "Remdesivir", "type": "DRUG" }, { "name": "Nirmatrelvir/ritonavir + remdesivir", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate + Ceftazidime + Macrolide", "type": "DRUG" }, { "name": "Meropenem + Macrolide", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "UMC Utrecht", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "28 Days", "maximum_age": null, "sex": "ALL", "summary": "28 Days and older" }, "enrollment_count": 20000, "start_date": "2016-04-11", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 11, "location_summary": "Jacksonville, Florida • Augusta, Georgia • Chicago, Illinois + 8 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02735707" }, { "nct_id": "NCT02286921", "title": "Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castration Resistant Metastatic Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Testosterone Enanthate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "18 Years to 80 Years · Male only" }, "enrollment_count": 222, "start_date": "2015-01", "completion_date": "2020-02-21", "has_results": true, "last_update_posted_date": "2020-11-06", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Duarte, California • Aurora, Colorado + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02286921" }, { "nct_id": "NCT07850804", "title": "Trial of NASHA Dx Urethral Bulking System", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urinary Incontinence", "Urinary Incontinence (UI)", "Urinary Incontinence , Stress", "Urinary Incontinence Due to Urethral Sphincter Incompetence", "Urethral Sphincter Activity", "Intrinsic Sphincter Deficiency", "Pelvic Floor Dysfunction" ], "interventions": [ { "name": "NASHA Dx", "type": "DEVICE" }, { "name": "Bulkamid", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Palette Life Sciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 314, "start_date": "2026-09", "completion_date": "2028-09", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 5, "location_summary": "Tustin, California • Lincoln, Nebraska • Charlotte, North Carolina + 2 more", "locations": [ { "city": "Tustin", "state": "California" }, { "city": "Lincoln", "state": "Nebraska" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Allentown", "state": "Pennsylvania" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07850804" }, { "nct_id": "NCT04317807", "title": "R33: Levetiracetam in Early Psychosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Early Psychosis" ], "interventions": [ { "name": "Levetiracetam Pill", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "16 Years to 40 Years" }, "enrollment_count": 65, "start_date": "2020-08-27", "completion_date": "2025-04-10", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04317807" }, { "nct_id": "NCT00075803", "title": "Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma", "Infection", "Leukemia" ], "interventions": [ { "name": "Fluconazole", "type": "DRUG" }, { "name": "Voriconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 600, "start_date": "2003-11", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2023-01-04", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 33, "location_summary": "Birmingham, Alabama • La Jolla, California • Stanford, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00075803" }, { "nct_id": "NCT06601686", "title": "Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Transcranial electrical stimulation (TES)", "type": "DEVICE" }, { "name": "Transcranial electrical stimulation with temporal interference (TES-TI)", "type": "DEVICE" }, { "name": "Sham stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 22, "start_date": "2025-01-08", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06601686" }, { "nct_id": "NCT03448575", "title": "Safer Use of Antipsychotics in Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Child Behavior Disorders" ], "interventions": [ { "name": "Control - Provider Medication Alert Only", "type": "OTHER" }, { "name": "Intervention - Alert + CAP Review AND Enhanced BH Access", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Years to 17 Years" }, "enrollment_count": 733, "start_date": "2018-03-29", "completion_date": "2021-12-24", "has_results": true, "last_update_posted_date": "2024-10-31", "last_synced_at": "2026-11-05T10:08:34.025Z", "location_count": 4, "location_summary": "Aurora, Colorado • Columbus, Ohio • Portland, Oregon + 1 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03448575" } ] }